跳至主要内容
临床试验/NCT07169773
NCT07169773已完成不适用

Comparison Between Convective Radiofrequency Water Vapor Thermal Ablation (REZUM) Versus Tamsulosin in Management of Lower Urinary Tract Symptoms in Patients With Benign Prostatic Enlargement

khaled Abdelsattar Gad Ibrahim1 个研究点 分布在 1 个国家目标入组 94 人开始时间: 2022年5月1日最近更新:
干预措施
相关药物

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
94
试验地点
1
主要终点
The International Prostate Symptom score (IPSS)

研究概览

简要总结

the investigators aimed to compare the efficacy and safety of Rezūm therapy for the management of benign prostatic hyperplasia (BPH) with Tamsulosin.

详细描述

So far, data from available studies point towards good clinical outcomes with a short-term risk of self-limiting minor complications. Its application has demonstrated clinical effectiveness and possesses specific benefits that distinguish it among other treatments. It is applicable to outpatient setting, is effective in preserving sexual function and is versatile in its ability to treat a variety of prostate gland morphology.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
50 Years 至 80 Years(Adult, Older Adult)
性别
Male
接受健康志愿者

入选标准

  • with prostate volumes of 30- 80 mL,
  • mild to mod LUTS
  • (maximum urinary flow rate [Q max] of <15 mL/s
  • International Prostate Symptom Score [IPSS] of >13)
  • PVR urine < 250 ml

排除标准

  • prostate cancer,
  • neurogenic bladder
  • urethral stricture,
  • urinary bladder stone
  • previous prostatic surgery

研究组 & 干预措施

Rezum group

Active Comparator

47 patient underwent Rezum therapy

干预措施: Rezum (Device)

tamsulosin group

Active Comparator

47 patients were given Tamsulosin medical treatment

干预措施: Tamsulosin (Drug)

结局指标

主要结局

The International Prostate Symptom score (IPSS)

时间窗: Time Frame: for each case in both groups the investigator assess IPSS at 3, 6, 12 after procedures through study completion, an average of 1 year

Measurement of The International Prostate Symptom score (IPSS) in both groups After 3, 6, 12 months of operation, the questioner is performed. Minimum :0 / Maximum : 35 Total score: 0-7 Mildly symptomatic; 8-19 moderately symptomatic; 20-35 severely symptomatic

The Maximum Urinary flow rate (Qmax)

时间窗: Time Frame: for each case in both groups the investigator assess Qmax at 3, 6, 12 months after procedures through study completion, an average of 1year

Measurement of The Maximum Urinary flow rate (Qmax) in both groups After 3, 6, 12 months of operation, the procedure is performed. Qmax is measured by (ml/sec) Normal values are described as a Qmax above 15 ml/sec and below 10 ml/sec is considered abnormal

The Quality of Life (QoL)

时间窗: [Time Frame: for each case in both groups the investigator assess QoL at 3, 6, 12 months after procedures through study completion, an average of 1 year

Measurement of The Quality of Life (QoL) in both groups After 3, 6, 12 months of operation, the questioner is performed. Minimum :0 means delighted / Maximum : 5 means unhappy

The Prostate size

时间窗: Time Frame: for each case in both groups the investigator assess prostate size at 3, 6, 12 months after procedures through study completion, an average of 1 year.

the prostate size was measured by grams by Trans-rectal ultra sound

次要结局

  • Incidence of complications(through 1 year)

研究者

发起方
khaled Abdelsattar Gad Ibrahim
申办方类型
Other
责任方
Sponsor Investigator
主要研究者

khaled Abdelsattar Gad Ibrahim

consultatnt doctor

Armed Forces College of Medicine, Cairo, Egypt

研究点 (1)

Loading locations...

相似试验